Table 2 Summary of adverse events observed during the study
Adverse event | Dexmedetomidine (nā=ā16) | Propofol (nā=ā10) | Total (nā=ā26) | |||
|---|---|---|---|---|---|---|
Subjects, n (%) | Events, n | Subjects, n (%) | Events, n | Subjects, n (%) | Events, n | |
Bradycardia | 1 (6.3) | 1 | Ā | Ā | 1 (3.8) | 1 |
Cardiac arrest | Ā | Ā | 1 (10.0) | 1 | 1 (3.8) | 1 |
Urinary tract infection | 1 (6.3) | 1 | Ā | Ā | 1 (3.8) | 1 |
Decreased cough efficiency | Ā | Ā | 1 (10.0) | 1 | 1 (3.8) | 1 |
Increased bronchial secretion | Ā | Ā | 1 (10.0) | 1 | 1 (3.8) | 1 |